TILRAY BRANDS INC (TLRY) Stock Price & Overview
NASDAQ:TLRY • US88688T2096
Current stock price
The current stock price of TLRY is 6.21 USD. Today TLRY is down by -6.76%. In the past month the price decreased by -19.87%. In the past year, price decreased by -4.46%.
TLRY Key Statistics
- Market Cap
- 723.527M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -14.37
- Dividend Yield
- N/A
TLRY Stock Performance
TLRY Stock Chart
TLRY Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to TLRY. When comparing the yearly performance of all stocks, TLRY is a bad performer in the overall market: 85.29% of all stocks are doing better.
TLRY Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TLRY. TLRY has a bad profitability rating. Also its financial health evaluation is rather negative.
TLRY Earnings
On January 8, 2026 TLRY reported an EPS of -0.41 and a revenue of 217.51M. The company missed EPS expectations (-100.98% surprise) and beat revenue expectations (1.09% surprise).
TLRY Forecast & Estimates
17 analysts have analysed TLRY and the average price target is 12.64 USD. This implies a price increase of 103.58% is expected in the next year compared to the current price of 6.21.
For the next year, analysts expect an EPS growth of 96.11% and a revenue growth 3.75% for TLRY
TLRY Groups
Sector & Classification
TLRY Financial Highlights
Over the last trailing twelve months TLRY reported a non-GAAP Earnings per Share(EPS) of -14.37. The EPS decreased by -379% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -100.42% | ||
| ROE | -133.4% | ||
| Debt/Equity | 0.18 |
TLRY Ownership
TLRY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.94 | 855.344B | ||
| JNJ | JOHNSON & JOHNSON | 20.21 | 566.915B | ||
| MRK | MERCK & CO. INC. | 22.06 | 282.297B | ||
| PFE | PFIZER INC | 9.03 | 153.415B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.08 | 117.056B | ||
| ZTS | ZOETIS INC | 16.34 | 48.828B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.78 | 26.166B | ||
| VTRS | VIATRIS INC | 5.26 | 15.198B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.8 | 11.922B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.026B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.799B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.144B | ||
| LGND | LIGAND PHARMACEUTICALS | 24.12 | 4.084B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TLRY
Company Profile
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
Company Info
IPO: 2018-07-19
TILRAY BRANDS INC
265 Talbot Street West
Leamington ONTARIO V9X 1J2 CA
CEO: Irwin D. Simon
Employees: 2842
Phone: 13026365400
TILRAY BRANDS INC / TLRY FAQ
Can you describe the business of TILRAY BRANDS INC?
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
What is the current price of TLRY stock?
The current stock price of TLRY is 6.21 USD. The price decreased by -6.76% in the last trading session.
Does TILRAY BRANDS INC pay dividends?
TLRY does not pay a dividend.
How is the ChartMill rating for TILRAY BRANDS INC?
TLRY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for TLRY stock?
17 analysts have analysed TLRY and the average price target is 12.64 USD. This implies a price increase of 103.58% is expected in the next year compared to the current price of 6.21.
Can you provide the sector and industry classification for TILRAY BRANDS INC?
TILRAY BRANDS INC (TLRY) operates in the Health Care sector and the Pharmaceuticals industry.